0000950170-24-139052.txt : 20241220 0000950170-24-139052.hdr.sgml : 20241220 20241220161503 ACCESSION NUMBER: 0000950170-24-139052 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241218 FILED AS OF DATE: 20241220 DATE AS OF CHANGE: 20241220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pimblett Emily CENTRAL INDEX KEY: 0001969365 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40708 FILM NUMBER: 241568120 MAIL ADDRESS: STREET 1: C/O ELIEM THERAPEUTICS, INC. STREET 2: 23515 NE NOVELTY HILL RD, STE B221 #125 CITY: REDMOND STATE: WA ZIP: 98053 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Climb Bio, Inc. CENTRAL INDEX KEY: 0001768446 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 832273741 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20 WILLIAM STREET STREET 2: SUITE 145 CITY: WELLESLEY HILLS STATE: MA ZIP: 02481 BUSINESS PHONE: 1-866-857-2596 MAIL ADDRESS: STREET 1: 20 WILLIAM STREET STREET 2: SUITE 145 CITY: WELLESLEY HILLS STATE: MA ZIP: 02481 FORMER COMPANY: FORMER CONFORMED NAME: Eliem Therapeutics, Inc. DATE OF NAME CHANGE: 20190219 4 1 ownership.xml 4 X0508 4 2024-12-18 0001768446 Climb Bio, Inc. CLYM 0001969365 Pimblett Emily C/O CLIMB BIO, INC. 20 WILLIAM STREET, SUITE 145 WELLESLEY HILLS MA 02481 false true false false CHIEF ACCOUNTING OFFICER true Common Stock 2024-12-18 4 M false 5000 A 12564 D Common Stock 2024-12-19 4 S false 1235 2.02 D 11329 D Restricted Stock Units 2024-12-18 4 M false 5000 0 D Common Stock 5000 25000 D Each restricted stock unit ("RSU") converted into one share of the Issuer's Common Stock. The sale reported on this Form 4 was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on April 27, 2024 to cover tax withholding obligations in connection with the vesting and settlement of the Reporting Person's RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The shares subject to this RSU shall vest at a rate of 1/8th of the total number of shares on the three-month anniversary of March 18, 2024 (the "March 2024 Vesting Commencement Date") and 1/8th of the total number of shares each three-month anniversary of the March 2024 Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the two-year anniversary of the March 2024 Vesting Commencement Date. /s/ Emily Pimblett 2024-12-20